Session Chair Profile

Ph.D., FACMG, Head of Global Medical Affairs, Invitae

Biography
Dr. Aradhya is a board-certified molecular geneticist and cytogeneticist who has helped shape professional practices and technology applications in clinical genetic testing over the past 15 years, he continues to encourage broader and earlier use of genetics in medicine through innovations in laboratory technologies, improving evidence-based clinical standards in genomics, and building mechanisms to empower individuals to access their genetic information. Before Invitae, Swaroop was VP and Director of Neurogenetics and for Clinical Microarray Services at GeneDx. He completed medical genetics training in 2007 at Stanford University and received his Ph.D. in molecular and human genetics in 2001 at Baylor College of Medicine. Over his career, he has contributed to the Human Genome Project, helped characterize several genetic disorders, and served on the Board of Directors of the American Board of Medical Genetics. He currently participates in the NIH ClinGen effort and is an adjunct Clinical Associate Professor of Pathology at Stanford University.


 Session Abstract – PMWC 2022 Silicon Valley


Track Chair:
Swaroop Aradhya, Invitae

Genetic testing has evolved over time and various applications have successfully made it into the clinical setting. While oncology applications are dominating, we also see a rise in genetic/genomic applications for reproductive health, CVD diagnosis, or early life understanding. Technological advancements are required to scale genetic testing applications delivery including relay of genomic information to clinicians and patients. In parallel to technological challenges, hurdles are also observed when it comes to insight/knowledge extraction, reporting of clinical findings, and scaling of genetic counseling. This track will touch upon these various aspects including successful precision medicine models through biopharma ventures for rare disease understanding and direct to consumer genetic testing.

Sessions:

  • The Path to Universal Newborn Sequencing and Disease Prevention
    - Robert C Green, Harvard
  • Intro to Genetic Testing Applications
    - Swaroop Aradhya, Invitae
  • Evolving Paradigms in Genetic Testing Initiated by Consumers
    - Paldeep S. Atwal, PWN Health
  • Models of Successful Precision Medicine through Biopharma Ventures in Rare Disease
    - Daniel Anderson, Invitae
  • Pairing Somatic Cancer Testing with Germline Testing
    - Ed Esplin, Invitae
  • Scalable Approaches to Relaying Genomic Information to Clinicians and their Patients
    - Steven Bleyl, Genome Medical
    - Cassie Hajek, Sanford Imagenetics
  • Lessons Learned from Virtual Genetic Counseling
    - Peter Hulick , NorthShore
  • Sharing Insights On Reimbursement
    - Ashley Arthur, Illumina